MX2017011990A - Metodo de preparacion de la forma a cristalina de pci-32765. - Google Patents
Metodo de preparacion de la forma a cristalina de pci-32765.Info
- Publication number
- MX2017011990A MX2017011990A MX2017011990A MX2017011990A MX2017011990A MX 2017011990 A MX2017011990 A MX 2017011990A MX 2017011990 A MX2017011990 A MX 2017011990A MX 2017011990 A MX2017011990 A MX 2017011990A MX 2017011990 A MX2017011990 A MX 2017011990A
- Authority
- MX
- Mexico
- Prior art keywords
- pci
- crystal form
- crystal
- preparation
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
- G01N23/20075—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials by measuring interferences of X-rays, e.g. Borrmann effect
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
- G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method
Abstract
Se describe un método de preparación de una Forma A cristalina de PCI-32765. El método de preparación comprende las siguientes etapas: 1) disolver un sólido alcalino libre de PCI-32765 en un solvente positivo; 2) agregar gota a gota la solución de la etapa 1) en un anti-solvente, agitar después que se completa el agregado gota a gota, y agregar una semilla de cristal de la forma A de cristal PCI-32765, o agregar la solución de la etapa 1) en un líquido de suspensión que contiene la semilla de cristal de la forma A de cristal PCI-32765; 3) controlar el sistema de solución obtenido en la etapa 2) para agitar continuamente, y madurar para obtener magma de cristal; y 4) filtrar, lavar y secar el magma de cristal para obtener polvo de la forma A de cristal PCI-32765. El método de preparación tiene las características de simplicidad en la operación de proceso, proceso estable y controlable, alto rendimiento, protección ambiental, buena capacidad de remoción de impurezas e idoneidad para producción industrial. Además, la forma A de cristal preparada puede almacenarse establemente, y la higroscopicidad y la solubilidad de la forma A de cristal preparada reúne los requerimientos para uso medicinal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510126412 | 2015-03-20 | ||
PCT/CN2016/076779 WO2016150349A1 (zh) | 2015-03-20 | 2016-03-18 | 一种pci-32765晶型a的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017011990A true MX2017011990A (es) | 2018-06-06 |
Family
ID=56310982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017011990A MX2017011990A (es) | 2015-03-20 | 2016-03-18 | Metodo de preparacion de la forma a cristalina de pci-32765. |
Country Status (9)
Country | Link |
---|---|
US (1) | US10138239B2 (es) |
EP (1) | EP3272753B1 (es) |
JP (1) | JP6657269B2 (es) |
CN (1) | CN105669679A (es) |
AU (1) | AU2016236578B2 (es) |
CA (1) | CA2980418C (es) |
IL (1) | IL254530A0 (es) |
MX (1) | MX2017011990A (es) |
WO (1) | WO2016150349A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10183024B2 (en) | 2016-12-02 | 2019-01-22 | Apotex Inc. | Crystalline forms of ibrutinib |
CN106831788B (zh) * | 2017-01-22 | 2020-10-30 | 鲁南制药集团股份有限公司 | 伊布替尼精制方法 |
WO2019070698A1 (en) | 2017-10-02 | 2019-04-11 | Johnson Matthey Public Limited Company | NEW FORMS OF IBRUTINIB |
CZ2017787A3 (cs) | 2017-12-08 | 2019-06-19 | Zentiva, K.S. | Farmaceutické kompozice obsahující ibrutinib |
WO2019195827A1 (en) | 2018-04-06 | 2019-10-10 | Johnson Matthey Public Limited Company | Novel form of ibrutinib |
EP3575300A1 (en) | 2018-05-31 | 2019-12-04 | Apotex Inc. | Novel crystalline forms of ibrutinib |
CN115639091B (zh) * | 2022-12-21 | 2023-03-17 | 南通嘉鹏新材料科技有限公司 | 一种聚酯热熔胶的硬度检测设备 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ702548A (en) * | 2012-06-04 | 2015-11-27 | Pharmacyclics Llc | Crystalline forms of a bruton’s tyrosine kinase inhibitor |
CN103121999A (zh) | 2012-08-29 | 2013-05-29 | 苏州迪飞医药科技有限公司 | 一种酪氨酸激酶抑制剂pci-32765的合成方法 |
PT2914296T (pt) * | 2012-11-01 | 2018-10-30 | Infinity Pharmaceuticals Inc | Tratamento de cancros utilizando moduladores de isoformas de pi3-quinase |
CN103694241A (zh) | 2013-11-27 | 2014-04-02 | 苏州晶云药物科技有限公司 | Pci-32765的新晶型a及其制备方法 |
-
2016
- 2016-03-18 EP EP16767726.9A patent/EP3272753B1/en active Active
- 2016-03-18 AU AU2016236578A patent/AU2016236578B2/en not_active Ceased
- 2016-03-18 MX MX2017011990A patent/MX2017011990A/es active IP Right Grant
- 2016-03-18 CN CN201610156820.9A patent/CN105669679A/zh active Pending
- 2016-03-18 CA CA2980418A patent/CA2980418C/en active Active
- 2016-03-18 US US15/559,777 patent/US10138239B2/en not_active Expired - Fee Related
- 2016-03-18 WO PCT/CN2016/076779 patent/WO2016150349A1/zh active Application Filing
- 2016-03-18 JP JP2017567523A patent/JP6657269B2/ja not_active Expired - Fee Related
-
2017
- 2017-09-17 IL IL254530A patent/IL254530A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL254530A0 (en) | 2017-11-30 |
EP3272753A1 (en) | 2018-01-24 |
AU2016236578A1 (en) | 2017-10-12 |
WO2016150349A1 (zh) | 2016-09-29 |
EP3272753A4 (en) | 2018-07-25 |
US10138239B2 (en) | 2018-11-27 |
US20180065958A1 (en) | 2018-03-08 |
EP3272753B1 (en) | 2020-03-04 |
CA2980418A1 (en) | 2016-09-29 |
JP6657269B2 (ja) | 2020-03-04 |
CA2980418C (en) | 2019-07-09 |
AU2016236578B2 (en) | 2019-04-04 |
JP2018508584A (ja) | 2018-03-29 |
CN105669679A (zh) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017011990A (es) | Metodo de preparacion de la forma a cristalina de pci-32765. | |
EA201791004A1 (ru) | Улучшенные устройства и способ переработки свинцово-кислотных аккумуляторов, не требующий плавления | |
WO2016161989A3 (zh) | 一种硫酸氢氯吡格雷i晶型球形结晶的制备方法 | |
MX2018006969A (es) | Método de preparación de la forma ii hidrato del cocristal de valasartán y ahu-377 trisódico. | |
GB201319253D0 (en) | Extraction of carboxylic acids with tin compounds | |
PH12015501877B1 (en) | Suspension for oral administration comprising amorphous tolvaptan | |
MX2017014958A (es) | Metodo de produccion de forma cristalina de enzalutamida. | |
JP2014520848A5 (es) | ||
CN103102351B (zh) | 一种制备高纯度叶酸的精制方法 | |
PH12020500586A1 (en) | Process for preapring large size isoxazoline particles | |
AR081267A1 (es) | Procedimiento de obtencion de la forma cristalina a del febuxostat | |
PH12019500435A1 (en) | Method for producing scandium compound, and scandium compound | |
PH12019500477A1 (en) | Method for producing high-purity scandium oxide | |
CN101423231A (zh) | 固体单氰胺的提纯方法 | |
CN204625828U (zh) | 一种结晶室 | |
JP2018502813A5 (es) | ||
CN105315300B (zh) | 一种头孢西丁钠、其制备方法及用途 | |
WO2019043587A3 (en) | A process for the preparation of treosulfan | |
GB2565419A (en) | Process for preparing novel crystalline form of mesosulfuron-methyl and use thereof | |
CN103755581B (zh) | 一种d,l-亮氨酸的拆分方法 | |
JP2012193074A5 (es) | ||
CN103275165B (zh) | 一种大孔吸附树脂提取茶皂素的方法 | |
MX2017007376A (es) | Proceso para producir anhidrido 4-azidosulfonilftalico. | |
EA201991781A1 (ru) | Способ обработки титансодержащего шлака | |
GB2555344A (en) | Process for preparing novel crystalline form of iodosulfuron-methyl-sodium and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |